In cancer, pleiotropic responses to TGF-β lead to a diverse array of genetic responses, ranging from cytotoxic and apoptotic tumor suppressor responses in early tumors to proliferation, invasion, angiogenesis, and carcinogenesis in advanced cancers 11. The gene discussed is TGFB1; the disease is neoplasm.